MedicaidPrior AuthLow impact
Elelyso® (taliglucerase alfa) (New)
Humana·IN · Endocrinology, Hematology, Internal Medicine +1 more·Medicaid
Effective date
Jun 1, 2026
We identified it
Jun 24, 2026
Summary
New prior authorization policy for Elelyso (taliglucerase alfa) for Type 1 Gaucher disease treatment, requiring confirmed diagnosis before approval. This is a brand new policy for Indiana Medicaid members only.
Action Required
By June 1, 2026: Billing team must implement prior authorization requirements for Elelyso (taliglucerase alfa) prescriptions for Indiana Medicaid patients with Type 1 Gaucher disease. Update pharmacy billing system to flag this medication for prior auth. Providers must document confirmed Type 1 Gaucher disease diagnosis. Claims will be denied without proper authorization.